Early complete response of primary bone marrow B‐cell lymphoma treated with rituximab‐based CHOP therapy, assessed by flow cytometry and immunogloblin heavy chain rearrangement

Evaluation of early response by flow cytometry and immunogloblin heavy chain assessments against primary bone marrow B‐cell lymphoma could be valuable for predicting treatment outcome.

Detalles Bibliográficos
Autores principales: Nabe, Yoshimi, Kikuchi, Shohei, Kamihara, Yusuke, Wada, Akinori, Murakami, Jun, Sato, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365553/
https://www.ncbi.nlm.nih.gov/pubmed/34430019
http://dx.doi.org/10.1002/ccr3.4657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365553/
https://www.ncbi.nlm.nih.gov/pubmed/34430019
http://dx.doi.org/10.1002/ccr3.4657

Ejemplares similares